Table of Contents
ISRN Oncology
Volume 2011, Article ID 560503, 8 pages
http://dx.doi.org/10.5402/2011/560503
Research Article

Differentiated Thyroid Cancer in Navarra (Spain): Historic Cohort Results (1987–2003)

1Department of Surgery, Complejo Hospitalario de Navarra, Irunlarrea street 3, 31008 Pamplona, Spain
2Department of Pathology, Complejo Hospitalario de Navarra, Irunlarrea street 3, 31008 Pamplona, Spain
3Department of Preventive Medicine, Complejo Hospitalario de Navarra, Irunlarrea street 3, 31008 Pamplona, Spain
4Department of Endocrinology, Complejo Hospitalario de Navarra, Irunlarrea street 3, 31008 Pamplona, Spain
5Department of Endocrinology and Nutrition, Hospital Universitario Central de Asturias, Celestino Villamil Street s/n, 33006 Oviedo, Spain

Received 17 May 2011; Accepted 14 June 2011

Academic Editors: E. Boven and C. N. Qian

Copyright © 2011 María Pilar Salvador Egea et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. L. Carvajal and M. P. Santamaría, “Epidemiología del cáncer diferenciado de tiroides,” Endocrinologia y Nutricion, vol. 52, no. 1, pp. 2–10, 2005. View at Google Scholar · View at Scopus
  2. J. L. Ponce Marco, “Cáncer de tiroides,” in Cirugía AEC: Manual de la Asociación Española de Cirujanos, J. L. L. Garcia, Ed., chapter 67, pp. 630–645, Médica Panamericana, Madrid, Spain, 1st edition, 2005. View at Google Scholar
  3. A. Sitges Serra and J. Sancho Inserser, “Carcinoma diferenciado de tiroides, carcinoma medular de tiroides, carcinoma anaplásico de tiroides y linfoma tiroideo,” in Guías Clínicas de la Asociación Española de Cirujanos, A. S. Serra and J. S. Inserser, Eds., Cirugía Endocrina, chapter 2, pp. 27–50, Arán Ediciones, Madrid, Spain, 1st edition, 1999. View at Google Scholar
  4. G. Riesco-Eizaguirre and P. Santisteban, “Molecular biology of thyroid cancer initiation,” Clinical and Translational Oncology, vol. 9, no. 11, pp. 686–693, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Schlumberger, G. Berg, O. Cohen et al., “Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective,” European Journal of Endocrinology, vol. 150, no. 2, pp. 105–112, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. E. M. Torre, M. T. L. Carballo, R. M. R. Erdozáin, L. F. Llenas, M. J. G. Iriarte, and J. J. B. Layana, “Prognostic value of thyroglobulin serum levels and 131I whole-body scan after initial treatment of low-risk differentiated thyroid cancer,” Thyroid, vol. 14, no. 4, pp. 301–306, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Biondi, S. Filetti, and M. Schlumberger, “Thyroid-hormone therapy and thyroid cancer,” Nature clinical practice. Endocrinology & Metabolism, vol. 1, no. 1, pp. 32–40, 2005. View at Publisher · View at Google Scholar
  8. S. I. Sherman, P. Angelos, D. W. Ball et al., “Thyroid carcinoma,” Journal of the National Comprehensive Cancer Network, vol. 3, no. 3, pp. 404–457, 2005. View at Google Scholar · View at Scopus
  9. A. L. Jiménez and A. S. Serra, “Cáncer diferenciado de tiroides. Avance en el tratamiento quirúrgico,” Endocrinología y Nutrición, vol. 52, pp. 11–17, 2005. View at Google Scholar
  10. A. Machens and H. Dralle, “Decreasing tumor size of thyroid cancer in Germany: institutional experience 1995–2009,” European Journal of Endocrinology, vol. 163, no. 1, pp. 111–119, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Machens and H. Dralle, “Failure to consider the number of dissected sides can bias complication rate calculations of central lymph node dissection for thyroid cancer,” Archives of Surgery, vol. 145, no. 10, pp. 1026–1027, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Frasoldati, M. Pesenti, M. Gallo, A. Caroggio, D. Salvo, and R. Valcavi, “Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma,” Cancer, vol. 97, no. 1, pp. 90–96, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Sánchez Franco, “Directrices en el tratamiento del carcinoma diferenciado de tiroides,” Endocrinologia y Nutricion, vol. 52, no. 1, pp. 23–31, 2005. View at Google Scholar · View at Scopus
  14. E. L. Mazzaferri and S. M. Jhiang, “Long-term impact of initial surgical and medical therapy of papillary and follicular thyroid cancer,” American Journal of Medicine, vol. 97, no. 5, pp. 449–500, 1994. View at Google Scholar
  15. J. Rosai, M. L. Carcangiu, A. Ronald, and M. D. Delellis, Atlas of Tumor Pathology: Tumors of Parathyroid Glands, 3rd series, Armed Forces Institute of Pathology, Washington, DC, USA, 1992.
  16. F. Pacini, M. Schlumberger, H. Dralle, R. Elisei, J. W. A. Smit, and W. Wiersinga, “European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium,” European Journal of Endocrinology, vol. 154, no. 6, pp. 787–803, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Cooper, G. Doherthy, B. Haugen et al., “Manegement guidelines for patients with thyroid nodules and differentiated thyroid cancer. American Thyroid Asociation,” Thyroid, vol. 16, no. 2, pp. 109–142, 2006. View at Google Scholar
  18. R. L. Witt and A. M. McNamara, “Prognostic factors in mortality and morbidity in patients with differentiated thyroid cancer,” Ear, Nose and Throat Journal, vol. 81, no. 12, pp. 856–863, 2002. View at Google Scholar · View at Scopus
  19. A. R. Zambudio, J. M. Rodríguez, R. Moya et al., “Los alelos HLA-CW7 y CW1 como factores de mal pronóstico en el carcinoma diferenciado de tiroides en el sudeste español,” Cirugia Espanola, vol. 72, no. 2, pp. 44–45, 2002. View at Google Scholar
  20. B. K. Kinder, “Well differentiated thyroid cancer,” Current Opinion in Oncology, vol. 15, no. 1, pp. 71–77, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. E. L. Mazzaferri, “Long-term outcome of patients with differentiated thyroid carcinoma: effect of therapy,” Endocrine Practice, vol. 6, no. 6, pp. 469–476, 2000. View at Google Scholar
  22. E. L. Mazzaferri, “An overview of the management of papillary and follicular thyroid carcinoma,” Thyroid, vol. 9, no. 5, pp. 421–427, 1999. View at Google Scholar · View at Scopus
  23. S. Sancho Fornos, J. V. Urbaneja, J. L. P. Marco, R. P. Jiménez, and C. H. Vela, “Complicaciones de la cirugía tiroidea,” Cirugia Espanola, vol. 69, no. 3, pp. 198–203, 2001. View at Google Scholar
  24. R. Scheiden, M. Keipes, and C. Bock, “Thyroid cancer in Luxembourg: a national population-based data report (1983–1999),” BioMed Central Cancer, vol. 24, no. 6, pp. 100–102, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Sheth and U. M. Hamper, “Role of sonography after total thyroidectomy for thyroid cancer,” Ultrasound Quarterly, vol. 24, no. 3, pp. 147–154, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Rago and P. Vitti, “Role of thyroid ultrasound in the diagnostic evaluation of thyroid nodules,” Clinical Endocrinology and Metabolism, vol. 22, no. 6, pp. 913–928, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. S. I. Sherman, “Thyroid carcinoma,” The Lancet, vol. 361, no. 9356, pp. 501–511, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. A. R. Shaha, “Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer,” Laryngoscope, vol. 114, no. 3, pp. 393–402, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. E. L. Mazzaferri and R. T. Kloos, “Current approaches to primary therapy for papillary and follicular thyroid cancer,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 4, pp. 1447–1463, 2001. View at Publisher · View at Google Scholar
  30. A. R. Ready and A. D. Barnes, “Complicaciones de la tiroidectomía,” British Journal of Surgery, vol. 81, no. 11, pp. 1555–1556, 1994. View at Publisher · View at Google Scholar · View at Scopus
  31. N. J. P. Beasley, P. G. Walfish, I. Witterick, and J. L. Freeman, “Cause of death in patients with well-differentiated thyroid carcinoma,” Laryngoscope, vol. 111, no. 6, pp. 989–991, 2001. View at Google Scholar · View at Scopus
  32. A. Stojadinovic, M. Shoup, A. Nissan et al., “Recurrent differentiated thyroid carcinoma: biological implications of age, method of detection, and site and extent of recurrence,” Annals of Surgical Oncology, vol. 9, no. 8, pp. 789–798, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. E. L. Mazzaferri, R. J. Robbins, C. A. Spencer et al., “A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 4, pp. 1433–1441, 2003. View at Publisher · View at Google Scholar
  34. M. Schlumberger, F. Pacini, W. M. Wiersinga et al., “Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice,” European Journal of Endocrinology, vol. 151, no. 5, pp. 539–548, 2004. View at Publisher · View at Google Scholar · View at Scopus